SPDR S&P Biotech ETF $XBI Holdings Decreased by Lion Street Advisors LLC

Lion Street Advisors LLC trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,148 shares of the exchange traded fund’s stock after selling 220 shares during the quarter. Lion Street Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $344,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently added to or reduced their stakes in XBI. JPMorgan Chase & Co. increased its stake in SPDR S&P Biotech ETF by 625.1% during the first quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock valued at $840,983,000 after purchasing an additional 12,344,558 shares during the last quarter. Goldman Sachs Group Inc. grew its position in shares of SPDR S&P Biotech ETF by 33.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock valued at $1,096,866,000 after buying an additional 3,353,029 shares during the last quarter. Simplex Trading LLC grew its position in shares of SPDR S&P Biotech ETF by 116.1% during the 1st quarter. Simplex Trading LLC now owns 241,039 shares of the exchange traded fund’s stock valued at $19,548,000 after buying an additional 1,741,445 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. bought a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter valued at about $85,155,000. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new position in shares of SPDR S&P Biotech ETF during the first quarter valued at approximately $48,660,000.

SPDR S&P Biotech ETF Trading Up 0.3%

NYSEARCA:XBI opened at $105.27 on Tuesday. The firm has a market capitalization of $6.23 billion, a PE ratio of 11.47 and a beta of 0.97. The stock has a 50 day moving average of $94.35 and a 200-day moving average of $85.92. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $107.26.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.